Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background
单位：[1]China-Japan Friendship Hospital, National Clinical Research Centre for Respiratory Diseases, Capital Medical University, Beijing, China[2]Department of Pulmonary and Critical Care Medicine, Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[3]Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[4]Institute of Respiratory Medicine, Chinese Academy of Medical Science, National Clinical Research Centre of Respiratory Diseases, Beijing, China[5]Tsinghua University-Peking University Joint Centre for Life Sciences, Beijing, China[6]Department of Lung Transplantation, Centre for Lung Transplantation, Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[7]Beijing GensKey Technology Co., Ltd, Beijing, China
National Key R&D Program of China [2017YFC1309301, 2017YFC1309300]; CAMS Innovation Fund for Medical Sciences [CIFMS 2018-I2M-1-003]; National Science Grant for Distinguished Young Scholars [81425001/H0104]
第一作者单位：[1]China-Japan Friendship Hospital, National Clinical Research Centre for Respiratory Diseases, Capital Medical University, Beijing, China[2]Department of Pulmonary and Critical Care Medicine, Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[3]Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[4]Institute of Respiratory Medicine, Chinese Academy of Medical Science, National Clinical Research Centre of Respiratory Diseases, Beijing, China[5]Tsinghua University-Peking University Joint Centre for Life Sciences, Beijing, China
共同第一作者：
通讯作者：
通讯机构：[1]China-Japan Friendship Hospital, National Clinical Research Centre for Respiratory Diseases, Capital Medical University, Beijing, China[2]Department of Pulmonary and Critical Care Medicine, Centre for Respiratory Diseases, China-Japan Friendship Hospital, Beijing, China[3]Laboratory of Clinical Microbiology and Infectious Diseases, Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Beijing, China[4]Institute of Respiratory Medicine, Chinese Academy of Medical Science, National Clinical Research Centre of Respiratory Diseases, Beijing, China[5]Tsinghua University-Peking University Joint Centre for Life Sciences, Beijing, China
推荐引用方式(GB/T 7714)：
Lingxiao Sun,Wenhui Chen,Haibo Li,et al.Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background[J].JOURNAL of ANTIMICROBIAL CHEMOTHERAPY.2020,75(10):3072-3074.doi:10.1093/jac/dkaa241.
APA：
Lingxiao Sun,Wenhui Chen,Haibo Li,Lifeng Li,Xiaohui Zou...&Bin Cao.(2020).Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background.JOURNAL of ANTIMICROBIAL CHEMOTHERAPY,75,(10)
MLA：
Lingxiao Sun,et al."Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background".JOURNAL of ANTIMICROBIAL CHEMOTHERAPY 75..10(2020):3072-3074
医学